Company Filing History:
Years Active: 2016
Title: Frédèric Zecri: Innovator in Pharmaceutical Chemistry
Introduction
Frédèric Zecri is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on tetrahydro-pyrido-pyrimidine derivatives. His research focuses on compounds that have the potential to treat disorders mediated by the activity of PI3K enzymes.
Latest Patents
Frédèric Zecri holds a patent for his invention titled "Tetrahydro-pyrido-pyrimidine derivatives." This patent encompasses substituted tetrahydro-pyrido-pyrimidine derivatives of the formula (I), where Y, R, and m are defined in the description. The compounds developed by Zecri are promising candidates for therapeutic applications in various diseases.
Career Highlights
Zecri is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to engage in cutting-edge research and development in the pharmaceutical sector. With a focus on innovative solutions, he has contributed to advancing medical science.
Collaborations
Throughout his career, Frédèric Zecri has collaborated with esteemed colleagues, including Nigel Graham Cooke and Nicolas Soldermann. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Frédèric Zecri's contributions to pharmaceutical chemistry, particularly through his patented work on tetrahydro-pyrido-pyrimidine derivatives, highlight his role as an innovator in the field. His ongoing work at Novartis AG continues to pave the way for advancements in medical treatments.